189 related articles for article (PubMed ID: 23395515)
1. Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences.
Marcucci M; Smith CT; Douketis JD; Tosetto A; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
J Clin Epidemiol; 2013 Apr; 66(4):415-25. PubMed ID: 23395515
[TBL] [Abstract][Full Text] [Related]
2. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
3. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
[TBL] [Abstract][Full Text] [Related]
6. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
Smith CT; Williamson PR; Marson AG
J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
[TBL] [Abstract][Full Text] [Related]
7. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
9. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
Palareti G
Expert Rev Hematol; 2015 Feb; 8(1):79-88. PubMed ID: 25348806
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and venous thromboembolism.
Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
Cosmi B; Palareti G
Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
[TBL] [Abstract][Full Text] [Related]
14. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
16. D-dimer testing to determine the duration of anticoagulant therapy.
Palareti G; Cosmi B; Legnani C
Curr Opin Pulm Med; 2007 Sep; 13(5):393-7. PubMed ID: 17940483
[TBL] [Abstract][Full Text] [Related]
17. Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism.
Cosmi B; Palareti G
Thromb Res; 2010 Apr; 125 Suppl 2():S62-5. PubMed ID: 20434008
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
[TBL] [Abstract][Full Text] [Related]
19. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]